SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    UK-based Dushey Med Ltd strikes exclusive deal with US hemp firm

    By

    UK-based CBD wholesaler Dushey Med Ltd has struck an exclusive trans-Atlantic deal.

    The Nottinghamshire firm will import products from EcoGen Biosciences, a major manufacturer in the US, into Britain.

    EcoGen Biosciences is described as a ‘leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients, proprietary formulations, and private-label finished products in the United States’.

    Dushey Med Ltd – which is a member of the European Industrial Hemp Association – will now have exclusive rights to import its products to the UK.

    Robert Sidebottom, director at Dushey Med Ltd, said: “We are thrilled to formalise our partnership with EcoGen, the company has continued to demonstrate a commitment to success through the leadership of Garrett Bain, with whom we have been working with for over a year.

    “The exclusive deal to supply bulk EcoGen CBD and CBG products directly into the thriving UK market is very exciting.

    “As a result of our partnership, we now have access to one of the largest inventories of high-quality CBD and CBG products in the UK – if not Europe.”

    Garrett Bain, president of EcoGen Biosciences, said: “Working with Robert and the team at Dushey Med Ltd has been great as their standards and efficacy mirror that of EcoGen.

    “We are particularly happy to formalise this partnership that will position both companies as prime sellers of quality products in the cannabis space.”

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Sean Seddon

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free